These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 24598459)

  • 21. Mortality and its predictors among antiretroviral therapy naïve HIV-infected individuals with CD4 cell count ≥350 cells/mm(3) compared to the general population: data from a population-based prospective HIV cohort in Uganda.
    Masiira B; Baisley K; Mayanja BN; Kazooba P; Maher D; Kaleebu P
    Glob Health Action; 2014; 7():21843. PubMed ID: 24433941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Decade of Combination Antiretroviral Treatment in Asia: The TREAT Asia HIV Observational Database Cohort.
    AIDS Res Hum Retroviruses; 2016 Aug; 32(8):772-81. PubMed ID: 27030657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Late HIV Diagnosis but Earlier Antiretroviral Treatment Initiation in Northwest Spain: Impact of Current Treatment Guidelines.
    Cid-Silva P; Margusino-Framiñán L; Balboa-Barreiro V; Pernas-Souto B; Mena-De-Cea Á; Martín-Herranz I; Castro-Iglesias Á; Poveda E
    J Int Assoc Provid AIDS Care; 2019; 18():2325958218821940. PubMed ID: 30798655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies.
    Nash D; Katyal M; Brinkhof MW; Keiser O; May M; Hughes R; Dabis F; Wood R; Sprinz E; Schechter M; Egger M;
    AIDS; 2008 Nov; 22(17):2291-302. PubMed ID: 18981768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics and outcomes of adult Ethiopian patients enrolled in HIV care and treatment: a multi-clinic observational study.
    Melaku Z; Lamb MR; Wang C; Lulseged S; Gadisa T; Ahmed S; Habtamu Z; Alemu H; Assefa T; Abrams EJ
    BMC Public Health; 2015 May; 15():462. PubMed ID: 25934178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcomes of patients infected with HIV through use of injected drugs compared to patients infected through sexual transmission: late presentation, delayed anti-retroviral treatment and higher mortality.
    Suárez-García I; Sobrino-Vegas P; Dalmau D; Rubio R; Iribarren JA; Blanco JR; Gutierrez F; Montero Alonso M; Bernal E; Vinuesa García D; Del Amo J;
    Addiction; 2016 Jul; 111(7):1235-45. PubMed ID: 26890155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Universal test and treat is not associated with sub-optimal antiretroviral therapy adherence in rural South Africa: the ANRS 12249 TasP trial.
    Iwuji C; McGrath N; Calmy A; Dabis F; Pillay D; Newell ML; Baisley K; Porter K
    J Int AIDS Soc; 2018 Jun; 21(6):e25112. PubMed ID: 29890048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults.
    Siegfried N; Uthman OA; Rutherford GW
    Cochrane Database Syst Rev; 2010 Mar; 2010(3):CD008272. PubMed ID: 20238364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mortality and loss to follow-up among HIV-infected persons on long-term antiretroviral therapy in Latin America and the Caribbean.
    Carriquiry G; Fink V; Koethe JR; Giganti MJ; Jayathilake K; Blevins M; Cahn P; Grinsztejn B; Wolff M; Pape JW; Padgett D; Madero JS; Gotuzzo E; McGowan CC; Shepherd BE
    J Int AIDS Soc; 2015; 18(1):20016. PubMed ID: 26165322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunodeficiency at Antiretroviral Therapy Start: Five-Year Adult Data (2012-2017) Based on Evolving National Policies in Rural Mozambique.
    Arinze F; Gong W; Green AF; De Schacht C; Carlucci JG; Silva W; Claquin G; Tique JA; Stefanutto M; Graves E; Van Rompaey S; Alvim MFS; Tomo S; Moon TD; Wester CW
    AIDS Res Hum Retroviruses; 2020 Jan; 36(1):39-47. PubMed ID: 31359762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV treatment eligibility expansion and timely antiretroviral treatment initiation following enrollment in HIV care: A metaregression analysis of programmatic data from 22 countries.
    Tymejczyk O; Brazier E; Yiannoutsos C; Wools-Kaloustian K; Althoff K; Crabtree-Ramírez B; Van Nguyen K; Zaniewski E; Dabis F; Sinayobye JD; Anderegg N; Ford N; Wikramanayake R; Nash D;
    PLoS Med; 2018 Mar; 15(3):e1002534. PubMed ID: 29570723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up.
    Lin KY; Cheng CY; Li CW; Yang CJ; Tsai MS; Liu CE; Lee YT; Tang HJ; Wang NC; Lin TY; Lee YC; Lin SP; Huang YS; Zhang JY; Ko WC; Cheng SH; Hung CC;
    PLoS One; 2017; 12(6):e0179870. PubMed ID: 28665938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of the timing of antiretroviral therapy on the potential for normalization of immune status in human immunodeficiency virus 1-infected individuals.
    Okulicz JF; Le TD; Agan BK; Camargo JF; Landrum ML; Wright E; Dolan MJ; Ganesan A; Ferguson TM; Smith DM; Richman DD; Little SJ; Clark RA; He W; Ahuja SK
    JAMA Intern Med; 2015 Jan; 175(1):88-99. PubMed ID: 25419650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduction in early mortality on antiretroviral therapy for adults in rural South Africa since change in CD4+ cell count eligibility criteria.
    Lessells RJ; Mutevedzi PC; Iwuji CC; Newell ML
    J Acquir Immune Defic Syndr; 2014 Jan; 65(1):e17-24. PubMed ID: 23756374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub-Saharan Africa: systematic review and meta-analysis.
    Mugglin C; Estill J; Wandeler G; Bender N; Egger M; Gsponer T; Keiser O;
    Trop Med Int Health; 2012 Dec; 17(12):1509-20. PubMed ID: 22994151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Observed CD4 counts at entry into HIV care and at antiretroviral therapy prescription by age in the USA, 2004-18: a cohort study.
    Lee JS; Humes E; Hogan BC; Justice AC; Klein M; Gebo K; John Gill M; Silverberg MJ; Rebeiro P; Horberg M; Karris M; Rabkin C; Moore RD; Althoff KN;
    Lancet HIV; 2022 Mar; 9 Suppl 1():S2. PubMed ID: 35304844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: data from an HIV cohort study in India.
    Alvarez-Uria G; Naik PK; Pakam R; Midde M
    Glob Health Action; 2013 Sep; 6():21682. PubMed ID: 24028937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time to initiation of antiretroviral therapy in HIV-infected patients diagnosed with an opportunistic disease: a cohort study.
    Deconinck L; Yazdanpanah Y; Gilson RJ; Melliez H; Viget N; Joly V; Sabin CA
    HIV Med; 2015 Apr; 16(4):219-29. PubMed ID: 25522796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time to eligibility for antiretroviral therapy in adults with CD4 cell count > 500 cells/μL in rural KwaZulu-Natal, South Africa.
    McGrath N; Lessells RJ; Newell ML
    HIV Med; 2015 Sep; 16(8):512-8. PubMed ID: 25959724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evolution of CD4+ T cell count in HIV-1-infected adults receiving antiretroviral therapy with sustained long-term virological suppression.
    Byakwaga H; Murray JM; Petoumenos K; Kelleher AD; Law MG; Boyd MA; Emery S; Mallon PW; Cooper DA
    AIDS Res Hum Retroviruses; 2009 Jun; 25(6):756-76. PubMed ID: 19500017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.